498 related articles for article (PubMed ID: 23689739)
1. Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
Elgafor el Sharkwy IA
Arch Gynecol Obstet; 2013 Dec; 288(6):1231-6. PubMed ID: 23689739
[TBL] [Abstract][Full Text] [Related]
2. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
Vimala N; Mittal S; Kumar S
Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
[TBL] [Abstract][Full Text] [Related]
3. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
4. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
[TBL] [Abstract][Full Text] [Related]
5. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
Owonikoko KM; Arowojolu AO; Okunlola MA
J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
[TBL] [Abstract][Full Text] [Related]
6. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
7. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
8. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
Chaudhuri P; Majumdar A
Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
[TBL] [Abstract][Full Text] [Related]
9. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
[TBL] [Abstract][Full Text] [Related]
10. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Williams HM; Price MJ; Merriel A; Gee H; Lissauer D; Moorthy V; Tobias A; Deeks JJ; Widmer M; Tunçalp Ö; Gülmezoglu AM; Hofmeyr GJ; Coomarasamy A
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011689. PubMed ID: 29693726
[TBL] [Abstract][Full Text] [Related]
11. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
Chaudhuri P; Mandi S; Mazumdar A
J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
[TBL] [Abstract][Full Text] [Related]
12. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
Tewatia R; Rani S; Srivastav U; Makhija B
Arch Gynecol Obstet; 2014 Apr; 289(4):739-42. PubMed ID: 24045979
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of carbetocin and oxytocin efficacy in prevention of postpartum hemorrhage in women after cesarean section].
Jagielska I; Kazdepka-Ziemińska A; Kaczorowska A; Madej A; Kolossa T; Grabiec M
Ginekol Pol; 2015 Sep; 86(9):689-93. PubMed ID: 26665571
[TBL] [Abstract][Full Text] [Related]
14. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.
Othman ER; Fayez MF; El Aal DE; El-Dine Mohamed HS; Abbas AM; Ali MK
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):791-795. PubMed ID: 28040121
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
Elbohoty AE; Mohammed WE; Sweed M; Bahaa Eldin AM; Nabhan A; Abd-El-Maeboud KH
Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
[TBL] [Abstract][Full Text] [Related]
16. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Apr; (4):CD005457. PubMed ID: 22513931
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.
Singh G; Radhakrishnan G; Guleria K
Int J Gynaecol Obstet; 2009 Nov; 107(2):130-4. PubMed ID: 19628206
[TBL] [Abstract][Full Text] [Related]
18. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
Al-Sawaf A; El-Mazny A; Shohayeb A
J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
[TBL] [Abstract][Full Text] [Related]
20. Rectal misoprostol versus intramuscular oxytocin for prevention of post partum hemorrhage.
Shrestha A; Dongol A; Chawla CD; Adhikari RK
Kathmandu Univ Med J (KUMJ); 2011; 9(33):8-12. PubMed ID: 22610801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
